Long-Acting Injectable Medications: Strategies and Mechanistic Considerations
February 25, 2016
Session 2 of the 2016 Drug Design and Delivery Symposium
Join Jules Remenar to learn about the basics of Long-Acting Injectables (LAIs), including when to use them and how the technology has changed over the decades. The body of the presentation will also introduce techniques for reducing the solubility of molecules, materials approaches to controlling release, and the role of the biological response to foreign objects.
What You Will Learn
- Basic considerations for choosing to create an Long-Acting Injectables
- Molecular and formulation strategies for turning a daily oral medication into a Long-Acting Injectables
- Why biology makes it difficult to predict success from in vitro data
The Fine Print
ACS Webinars® does not endorse any products or services. The views expressed in this presentation are those of the presenters and do not necessarily reflect the views or policies of the American Chemical Society.
Experts
Julius Remenar
Alkermes
Annette Bak
Merck Research Laboratories
Co-Produced By
;void(0);){kind=link}